Sartorius Stedim Biotech SA Strategic Asset Allocation Index
Sartorius Stedim Biotech SA strategic asset allocation index. Sartorius Stedim Biotech SA (DIM) has a Strategic Asset Allocation Index of 59.5% as of September 2023. Strategic assets (PP&E of €1.56 Billion plus long-term investments of €-) total €1.56 Billion, measured against net assets of €2.63 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check DIM tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sartorius Stedim Biotech SA (2013–2022)
Strategic asset allocation index of Sartorius Stedim Biotech SA from 2013 to 2022. This chart shows how Sartorius Stedim Biotech SA's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of September 2023, the index stands at 59.5%, representing strategic assets of €1.56 Billion against net assets of €2.63 Billion EUR.
Sartorius Stedim Biotech SA Strategic Asset Allocation Index by Year (2013–2022)
Sartorius Stedim Biotech SA strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Sartorius Stedim Biotech SA from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see DIM stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.1% | €808.00 Million | €808.00 Million | €- | €2.51 Billion | ▼ -4.8 pp |
| 2021 | 36.9% | €640.24 Million | €640.24 Million | €- | €1.73 Billion | ▲ +2.0 pp |
| 2020 | 34.9% | €518.28 Million | €518.28 Million | €- | €1.48 Billion | ▼ -6.2 pp |
| 2019 | 41.2% | €485.17 Million | €470.09 Million | €15.08 Million | €1.18 Billion | ▲ +16.2 pp |
| 2018 | 25.0% | €260.90 Million | €255.26 Million | €5.64 Million | €1.04 Billion | ▼ -2.3 pp |
| 2017 | 27.3% | €239.92 Million | €228.12 Million | €11.81 Million | €879.45 Million | ▼ -2.5 pp |
| 2016 | 29.7% | €227.03 Million | €224.76 Million | €2.27 Million | €763.56 Million | ▼ -4.9 pp |
| 2015 | 34.6% | €224.21 Million | €222.88 Million | €1.33 Million | €647.22 Million | ▲ +3.5 pp |
| 2014 | 31.1% | €167.48 Million | €166.27 Million | €1.21 Million | €538.51 Million | ▼ -5.7 pp |
| 2013 | 36.8% | €177.16 Million | €175.86 Million | €1.30 Million | €481.84 Million | — |